Last Name


TitleClinical Assistant Professor
InstitutionUniversity of Houston College of Pharmacy
DepartmentClinical Sciences & Administration
AddressTexas Medical Center Campus, Room 310
1441 Moursund
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. McCoy C, Badowski M, Sherman E, Crutchley R, Smith E, Chastain DB. Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice. Pharmacotherapy. 2018 Jan; 38(1):86-107. PMID: 29105160.
      View in: PubMed
    2. Hwang GS, Bhat R, Crutchley RD, Trivedi MV. Impact of CYP2D6 polymorphisms on endoxifen concentrations and breast cancer outcomes. Pharmacogenomics J. 2018 Apr; 18(2):201-208. PMID: 28762370.
      View in: PubMed
    3. Kuten SA, Patel SJ, Baru A, Gaber AO, Crutchley RD, Ramanathan V, Knight RJ. Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction. Transpl Infect Dis. 2017 Jul 14. PMID: 28708266.
      View in: PubMed
    4. Crutchley RD, Guduru RC, Cheng AM. Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection. HIV AIDS (Auckl). 2016; 8:47-65. PMID: 27022304; PMCID: PMC4790521.
    5. Clay PG, Crutchley RD. Noninfectious Diarrhea in HIV Seropositive Individuals: a Review of Prevalence Rates, Etiology, and Management in the Era of Combination Antiretroviral Therapy. Infect Dis Ther. 2014 Dec; 3(2):103-22. PMID: 25388760; PMCID: PMC4269634.
    6. Patel TS, Crutchley RD, Tucker AM, Cottreau J, Garey KW. Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS. HIV AIDS (Auckl). 2013; 5:153-62. PMID: 23888120; PMCID: PMC3722035.
    7. Yeo QM, Crutchley R, Cottreau J, Tucker A, Garey KW. Crofelemer, a novel antisecretory agent approved for the treatment of HIV-associated diarrhea. Drugs Today (Barc). 2013 Apr; 49(4):239-52. PMID: 23616951.
      View in: PubMed
    8. Cottreau J, Tucker A, Crutchley R, Garey KW. Crofelemer for the treatment of secretory diarrhea. Expert Rev Gastroenterol Hepatol. 2012 Feb; 6(1):17-23. PMID: 22149578.
      View in: PubMed
    9. Crutchley RD, Gathe J, Mayberry C, Trieu A, Abughosh S, Garey KW. Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res Hum Retroviruses. 2012 May; 28(5):454-9. PMID: 21878055.
      View in: PubMed
    10. Crutchley RD, Ma Q, Sulaiman A, Hochreitter J, Morse GD. Within-patient atazanavir trough concentration monitoring in HIV-1-infected patients. J Pharm Pract. 2011 Apr; 24(2):216-22. PMID: 21712217.
      View in: PubMed
    11. Crutchley RD, Miller J, Garey KW. Crofelemer, a novel agent for treatment of secretory diarrhea. Ann Pharmacother. 2010 May; 44(5):878-84. PMID: 20388859.
      View in: PubMed
    12. Rezk NL, Crutchley RD, Yeh RF, Kashuba AD. Full validation of an analytical method for the HIV-protease inhibitor atazanavir in combination with 8 other antiretroviral agents and its applicability to therapeutic drug monitoring. Ther Drug Monit. 2006 Aug; 28(4):517-25. PMID: 16885719.
      View in: PubMed
    13. Rezk NL, Crutchley RD, Kashuba AD. Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Aug 5; 822(1-2):201-8. PMID: 16005269.
      View in: PubMed
    CRUTCHLEY's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Physical Neighbors Expand Description